Literature DB >> 1839801

Effect of inhibition of the mitochondrial ATPase on net myocardial ATP in total ischemia.

R B Jennings1, K A Reimer, C Steenbergen.   

Abstract

The effect of inhibition of the mitochondrial ATPase with oligomycin on the rate of ATP depletion and anaerobic glycolysis was studied in the totally ischemic dog heart. An oxygenated, buffered crystalloidal solution containing 10 microM oligomycin and 12 mM glucose was delivered at 100 mmHg pressure to the circumflex bed of the excised cooled heart. Buffered solution without oligomycin was delivered simultaneously to the anterior descending bed of the same heart. Little metabolic evidence of ischemia developed until the heart was made totally ischemic by incubating it in a sealed plastic bag at 37 degrees C. Successful inhibition of the mitochondrial ATPase was confirmed by the absence of both mitochondrial ATPase activity and the loss of respiratory control in mitochondria isolated from treated tissue. ATP, glycolytic intermediates and catabolites of the adenine nucleotide pool were measured in the control and treated beds at various intervals during 120 min of ischemia. Inhibition of the ATPase resulted in slowing of the rates of ATP depletion and anaerobic glycolysis (estimated by lactate accumulation). Also, degradation of the adenine nucleotide pool occurred more slowly in the inhibited group. These data establish that about 35% of the ATP utilization observed during the first 90 min of total ischemia in the canine heart is due to mitochondrial ATPase activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1839801     DOI: 10.1016/0022-2828(91)90185-o

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  35 in total

1.  Hypoxic preconditioning in isolated rat hearts: non-involvement of activation of adenosine A1 receptor, Gi protein, and ATP-sensitive K+ channel.

Authors:  K Yabe; Y Nasa; S Takeo
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

2.  Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation.

Authors:  Samarjit Das; Renee Wong; Nishadi Rajapakse; Elizabeth Murphy; Charles Steenbergen
Journal:  Circ Res       Date:  2008-09-18       Impact factor: 17.367

Review 3.  Regulation of mitochondrial ATP synthase in cardiac pathophysiology.

Authors:  Qinqiang Long; Kevin Yang; Qinglin Yang
Journal:  Am J Cardiovasc Dis       Date:  2015-03-20

4.  The inhibitor protein (IF1) of the F1F0-ATPase modulates human osteosarcoma cell bioenergetics.

Authors:  Simona Barbato; Gianluca Sgarbi; Giulia Gorini; Alessandra Baracca; Giancarlo Solaini
Journal:  J Biol Chem       Date:  2015-01-20       Impact factor: 5.157

Review 5.  Mitochondrial adenine nucleotide transport and cardioprotection.

Authors:  Samarjit Das; Charles Steenbergen
Journal:  J Mol Cell Cardiol       Date:  2011-09-17       Impact factor: 5.000

6.  Myocardial ischemic preconditioning and mitochondrial F1F0-ATPase activity.

Authors:  F Bosetti; G Yu; R Zucchi; S Ronca-Testoni; G Solaini
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

Review 7.  Mitochondrial and postmitochondrial survival signaling in cancer.

Authors:  Neelu Yadav; Dhyan Chandra
Journal:  Mitochondrion       Date:  2013-12-10       Impact factor: 4.160

Review 8.  Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion.

Authors:  Giancarlo Solaini; David A Harris
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

Review 9.  Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection.

Authors:  D Morin; R Assaly; S Paradis; A Berdeaux
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

10.  Ischemic preconditioning in isolated perfused mouse heart: reduction in infarct size without improvement of post-ischemic ventricular function.

Authors:  L Xi; M L Hess; R C Kukreja
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.